Delivery Order SPE2DX22D0029-SPE2D825F37UH
- Not listed
- This delivery order, awarded on July 28, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,433.04 with a firm fixed price structure, was issued through the Medical Supply Chain to support federal medical procurement needs. The contract is not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This delivery order, awarded July 30, 2025, to AmerisourceBergen Drug Corp represents a $9,374.82 firm fixed-price contract funded by the Defense Logistics Agency's Medical Supply Chain division. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support for military...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $40,628.97 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and the place of performance is located in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- This delivery order, awarded July 21, 2025, represents a $24,150.64 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain and AmerisourceBergen Drug Corp for pharmaceutical and medical supply fulfillment. The contract, which serves as a child order under a larger indefinite delivery vehicle, is scheduled for completion by July 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from...
- This delivery order, issued on July 24, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $5,077.31 for pharmaceutical and medical supplies through the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a non-set-aside, competitively awarded contract, this delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,062.16 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,534.00 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award...
- This delivery order, awarded July 21, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order carries a ceiling value of $48,329.76 and employs firm fixed pricing with an ultimate completion date of July 22, 2025. The award utilized no set-aside designation and was competitively awarded to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D825F37UHDelivery Order
This delivery order, awarded July 31, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,132.80 with a firm fixed price structure, is funded through the Medical Supply Chain division of the Department of Defense. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, with an ultimate completion date of August 1, 2025. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's substantial $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX and extending through December 2026) provides the underlying contract vehicle enabling this delivery order. Through this arrangement, the company supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and scalable pharmaceutical support capabilities to serve military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |